Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872348 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 8 Pages |
Abstract
Conclusions: Concurrent chemotherapy and V60 were associated with the development of severe AET ⥠Grade 3. For patients being treated with concurrent chemotherapy, V60 is considered to be a useful parameter predicting the risk of severe AET after conventionally fractionated 3D-CRT for lung cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tae Hyun M.D., Kwan Ho M.D., Hong Ryull M.D., Jin Soo M.D., Ji Youn M.D., Jae Ill M.D., Jong Mog M.D., Eun Kyoung M.D., Il Ju M.D., Sung Yong Ph.D., Kyung Hwan M.D., Dae Yong M.D., Joo Young M.D.,